• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Nurix Therapeutics Inc (NQ: NRIX )

    22.03 +1.79 (+8.84%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Jul 11, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,142,026
    Open 21.15
    Bid (Size) 21.50 (1)
    Ask (Size) 22.30 (5)
    Prev. Close 20.24
    Today's Range 20.57 - 22.79
    52wk Range 4.220 - 22.79
    Shares Outstanding 47,147,781
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Expert Outlook: Nurix Therapeutics Through The Eyes Of 14 Analysts
    Via Benzinga
    Stock Market Weekly Review: Nvidia, AI Chip Plays Hit Resistance
    The Nasdaq and S&P 500 backed off highs. The Dow regained a key level. 
    Via Investor's Business Daily
    Topics Artificial Intelligence Stocks
    Exposures Artificial Intelligence US Equities

    Performance

    YTD
    +115.56%
    +115.56%
    1 Month
    +36.41%
    +36.41%
    3 Month
    +28.01%
    +28.01%
    6 Month
    +135.61%
    +135.61%
    1 Year
    +120.74%
    +120.74%

    More News

    Read More
    Nvidia To Rally Around 53%? Here Are 10 Top Analyst Forecasts For Tuesday
    Via Benzinga
    What's Going On With Small-Cap Cancer Focused Nurix Therapeutics On Monday?
    Via Benzinga
    Why Nurix Therapeutics Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Peeling Back The Layers: Exploring Nurix Therapeutics Through Analyst Insights
    Via Benzinga
    Key Takeaways From Nurix Therapeutics Analyst Ratings
    Via Benzinga
    Biotech Stock Nurix Therapeutics Jumps On Positive Leukemia Treatment Trial
    Via Investor's Business Daily
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
    Via InvestorPlace
    Why JPMorgan Shares Are Trading Lower By Around 5%? Here Are Other Stocks Moving In Friday's Mid-Day Session
    Via Benzinga
    Critical Insights From Nurix Therapeutics Analyst Ratings: What You Need To Know
    Via Benzinga
    Analyst Scoreboard: 7 Ratings For Nurix Therapeutics
    Via Benzinga
    Applied Digital Reports Downbeat Results, Joins Nurix Therapeutics And Other Big Stocks Moving Lower In Friday's Pre-Market Session
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why NextPlat Shares Are Trading Higher By Around 30%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Via Benzinga
    Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Via Benzinga
    Enliven Therapeutics, Alpine Immune Sciences, Janux Therapeutics And Other Big Stocks Moving Higher On Thursday
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    NRIX Stock Earnings: Nurix Therapeutics Beats EPS, Misses Revenue for Q1 2024
    Via InvestorPlace
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Via Benzinga
    BlackBerry, Nurix Therapeutics, Tesla And Other Big Stocks Moving Higher On Tuesday
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Decoding 4 Analyst Evaluations For Nurix Therapeutics
    Via Benzinga
    Bit Digital, Cipher Mining And Other Big Stocks Moving Higher In Thursday's Pre-Market Session
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Judith A. Reinsdorf and Katherine M. Sandstrom Named to Toll Brothers Board of Directors
    From Toll Brothers, Inc.
    Via GlobeNewswire
    10 Health Care Stocks With Whale Alerts In Today's Session
    Via Benzinga
    Cathie Wood-Led Ark Invest Sells Over $6.5M Worth Of Tesla Stock, What's Going On?
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.